文献検索結果

2283件の論文が見つかりました。

キーワード: neoplasm, Neubildung, Neoplasma, 新生物

• 2024, Pinto R, Ardoino L, Giardullo P, Villani P, Marino C
  [高周波（100 kHz-300 GHz）電磁界ばく露と共発がん性についてのイン・ビトロ研究の系統的レビュー] [review]
  Int J Environ Res Public Health 21 (8): 1020
• 2024, Sarreshtehdari A, García-Sánchez T, Sánchez-Velázquez P, Ielpo B, Berjano E, Villamonte M, Moll X, Burdio F
  [ヒト肝臓組織における電気伝導率の測定：正常組織と腫瘍組織、ならびにイン・ビボとエクス・ビボ条件の評価] [med./bio.]
  Biosensors 14 (8): 382
• 2024, Shrivastava A, Kumar A, Aggarwal LM, Pradhan S, Choudhary S, Ashish A, Kashyap K, Mishra S
  [生体電気膜電位の進化：がんの病因および治療戦略への含意] [basics]
  J Membr Biol 257 (5-6): 281-305
• 2024, Wang L, Chen C, Xiao Y, Gong R, Shen J, Lu M
  [膠芽腫における腫瘍治療電界療法の電極アレイ配置の個別最適化戦略] [tech./dosim.]
  Int J Numer Method Biomed Eng 40 (10): e3859
• 2024, Wang C, Zhou G, Guo X, Zhang W, Wu C
  [電気刺激はがん細胞による磁性ナノ粒子のエンドサイトーシスを促進する] [med./bio.]
  Small 20 (46): e2403381
• 2024, Yan Z, Huang L, Zhang X, Yu X, Huang R
  [神経膠芽腫の増殖における抗PD-1免疫療法の強化を通じた革新的な腫瘍治療装置OM-100の抗腫瘍効果] [med./bio.]
  Sci Rep 14: 18444
• 2024, Schlieper-Scherf S, Hebach N, Hausmann D, Azorin DD, Hoffmann DC, Horschitz S, Maier E, Koch P, Karreman MA, Etminan N, Ratliff M
  [培養モデルにおける腫瘍治療電界療法（TTFields）を用いた神経膠芽腫ネットワークの破壊] [med./bio.]
  J Neurooncol 170 (1): 139-151
• 2024, Gökçek-Saraç Ç, Çetin E, Ateş K, Özen Ş, Karakurt S
  Different duration of exposure to a pulsed magnetic field can cause changes in mRNA expression of apoptotic genes in oleic acid-treated neuroblastoma cells [med./bio.]
  Int J Radiat Biol 100 (10): 1471-1480
• 2024, Lucia U, Bergandi L, Grisolia G, Fino D, Mareschi K, Marini E, Santa Banche Niclot AG, Tirtei E, Asaftei SD, Fagioli F, Ponzetto A, Silvagno F
  [超低周波電磁界へのばく露は二次元および三次元のヒト骨肉腫モデルの成長を抑制し、化学療法に対する感受性を増強する] [med./bio.]
  Biomed Pharmacother 177: 117162
• 2024, Yang X, Hu C, Li L
  [技術ノート：腫瘍治療電界療法のための熱管理スキームに関する計算研究] [tech./dosim.]
  Med Phys 51 (10): 7632-7644
• 2024, Dieper A, Scheidegger S, Füchslin RM, Veltsista PD, Stein U, Weyland M, Gerster D, Beck M, Bengtsson O, Zips D, Ghadjar P
  [文献レビュー：がんに対する外部の高周波電磁界の非熱的分子効果の可能性] [review]
  Int J Hyperthermia 41 (1): 2379992
• 2024, Favier A, Mathelin C, Gonzalez M, Uzan C
  [乳がん：職業ばく露疾患と見なすことができるか？] [foreign-language]
  Gynecol Obstet Fertil Senol 52 (11): 627-632
• 2024, Mrugala MM, Shi W, Iwomoto F, Lukas RV, Palmer JD, Suh JH, Glas M
  [2011-2022年に治療された25,000人以上の中枢神経系悪性腫瘍患者における腫瘍治療電界療法（TTFields）のグローバルな市販後安全監視] [epidem.]
  J Neurooncol 169: 25-38
• 2024, Woo SH, Jung BC, Kim JY, Lee YH, Kim YS
  PEMF Potentiates Doxorubicin-induced Late G2 Arrest in MDA-MB-231 Breast Cancer Cells [med./bio.]
  Anticancer Res 44 (7): 2837-2846
• 2024, Li X, Liu K, Guo C, Fang T, Yang F
  [Study on the mesoscopic dynamic effects of tumor treating fields on cell tubulin] [foreign-language]
  Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 41 (3): 569-576
• 2024, Cao X, Li J, Ren J, Peng J, Zhong R, He J, Xu T, Yu Z, Jin H, Hao S, Liu R, Xu B
  Minimally-invasive implantable device enhances brain cancer suppression [med./bio.]
  EMBO Mol Med 16 (7): 1704-1716
• 2024, Strack M, Kückelhaus J, Diebold M, Wuchter P, Huber PE, Schnell O, Sankowski R, Prinz M, Grosu AL, Heiland DH, Nicolay NH, Rühle A
  Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells [med./bio.]
  J Neurooncol 169 (2): 329-340
• 2024, Chen J, Liu Y, Lan J, Liu H, Tang Q, Li Z, Qiu X, Hu W, Xie J, Feng Y, Qin L, Zhang X, Liu J, Chen L
  Identification and validation of COL6A1 as a novel target for tumor electric field therapy in glioblastoma [med./bio.]
  CNS Neurosci Ther 30 (6): e14802
• 2024, Akimoto T, Islam MR, Nagasako A, Kishi K, Nakakaji R, Ohtake M, Hasumi H, Yamaguchi T, Yamada S, Yamamoto T, Ishikawa Y, Umemura M
  Alternative magnetic field exposure suppresses tumor growth via metabolic reprogramming [med./bio.]
  Cancer Sci 115 (8): 2686-2700
• 2024, Feychting M, Schüz J, Toledano MB, Vermeulen R, Auvinen A, Harbo Poulsen A, Deltour I, Smith RB, Heller J, Kromhout H, Huss A, Johansen C, Tettamanti G, Elliott P
  Response to the letter to the editor regarding “Mobile phone use and brain tumour risk − COSMOS, a prospective cohort study” [comment]
  Environ Int 189: 108808
• 2024, Zhang L, Ren Y, Peng Y, Luo Y, Liu Y, Wang X, Yang Y, Liu L, Ai P, Yang X, Li Y, Mao Q, Wang F
  Tumor treating fields for newly diagnosed high-grade glioma based on the criteria of 2021 WHO CNS5: A retrospective analysis of Chinese patients in a single center [med. app.]
  Cancer Med 13 (11): e7350
• 2024, Woo SH, Jung BC, Kim JY, Lee YH, Kim YS
  Pulsed Electromagnetic Field Enhances Caffeic Acid Phenethyl Ester-induced Death of MCF-7 Breast Cancer Cells [med./bio.]
  Anticancer Res 44 (6): 2407-2415
• 2024, Szlasa W, Sauer N, Baczyńska D, Ziętek M, Haczkiewicz-Leśniak K, Karpiński P, Fleszar M, Fortuna P, Kulus MJ, Piotrowska A, Kmiecik A, Barańska A, Michel O, Novickij V, Tarek M, Kasperkiewicz P, Dzięgiel P, Podhorska-Okołów M, Saczko J, Kulbacka J
  Pulsed electric field induces exocytosis and overexpression of MAGE antigens in melanoma [med./bio.]
  Sci Rep 14: 12546
• 2024, Bouaoun L, Byrnes G, Lagorio S, Feychting M, Abou-Bakre A, Beranger R, Schüz J
  [携帯電話使用からのがんリスクのモデリングに対する記憶想起バイアスおよび選択バイアスの影響：症例対照シミュレーション研究からの結果] [tech./dosim.]
  Epidemiology 35 (4): 437-446
• 2024, Smith CJ, Perfetti TA, Chokshi C, Venugopal C, Ashford JW, Singh SK
  Alkylating agents are possible inducers of glioblastoma and other brain tumors [review]
  Hum Exp Toxicol 43